Susan N Chi

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor
    Susan N Chi
    Dana Farber Cancer Institute, Children s Hospital Boston, Boston, MA, USA
    J Clin Oncol 27:385-9. 2009
  2. ncbi request reprint Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma
    Susan N Chi
    Division of Pediatric Oncology, New York University Medical Center, New York, NY, USA
    J Clin Oncol 22:4881-7. 2004
  3. ncbi request reprint A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
    Nathan J Robison
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts Division of Pediatric Hematology Oncology, Department of Pediatrics, Boston Children s Hospital, Boston, Massachusetts
    Pediatr Blood Cancer 61:636-42. 2014
  4. ncbi request reprint Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor
    Mary Ann Zimmerman
    Department of Pediatric Oncology, Pediatric Neuro Oncology, Dana Farber Cancer Institute, Rm SW331, 44 Binny Street, Boston, MA 02115, USA
    J Neurooncol 72:77-84. 2005
  5. doi request reprint Predictors of neoplastic disease in children with isolated pituitary stalk thickening
    Nathan J Robison
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston Children s Hospital, Boston, MA, USA
    Pediatr Blood Cancer 60:1630-5. 2013
  6. ncbi request reprint A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer
    Mark W Kieran
    Department of Pediatric Oncology, Dana Farber Cancer Institute, and Division of Pediatric Hematology Oncology, Children s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Pediatr Hematol Oncol 27:573-81. 2005
  7. ncbi request reprint Transverse myelitis after therapy for primitive neuroectodermal tumors
    Nicole J Ullrich
    Department of Neurology, Children s Hospital Boston and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Pediatr Neurol 35:122-5. 2006
  8. ncbi request reprint Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database
    Pratiti Bandopadhayay
    Division of Pediatric Hematology Oncology, Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston Children s Hospital, Boston, Massachusetts Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts
    Pediatr Blood Cancer 61:1173-9. 2014
  9. pmc Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors
    Mark W Kieran
    Director, Pediatric Medical Neuro Oncology, Dana Farber Cancer Institute and Boston Children s Hospital, Pediatric Hematology Oncology, Boston, MA 02215, USA
    Pediatr Blood Cancer 59:1155-7. 2012
  10. doi request reprint Sleep dysfunction in long term survivors of craniopharyngioma
    Peter E Manley
    Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Neurooncol 108:543-9. 2012

Collaborators

Detail Information

Publications14

  1. pmc Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor
    Susan N Chi
    Dana Farber Cancer Institute, Children s Hospital Boston, Boston, MA, USA
    J Clin Oncol 27:385-9. 2009
    ..Based on a previous pilot series, a prospective multi-institutional trial was conducted for patients with newly diagnosed CNS ATRT...
  2. ncbi request reprint Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma
    Susan N Chi
    Division of Pediatric Oncology, New York University Medical Center, New York, NY, USA
    J Clin Oncol 22:4881-7. 2004
    ..To evaluate the feasibility of and response rate to an intensified induction chemotherapy regimen for young children with newly diagnosed high-risk or disseminated medulloblastomas...
  3. ncbi request reprint A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
    Nathan J Robison
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts Division of Pediatric Hematology Oncology, Department of Pediatrics, Boston Children s Hospital, Boston, Massachusetts
    Pediatr Blood Cancer 61:636-42. 2014
    ..We undertook a prospective, open-label, single-arm, multi-institutional phase II study to evaluate the efficacy of a "5-drug" oral regimen in children with recurrent or progressive cancer...
  4. ncbi request reprint Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor
    Mary Ann Zimmerman
    Department of Pediatric Oncology, Pediatric Neuro Oncology, Dana Farber Cancer Institute, Rm SW331, 44 Binny Street, Boston, MA 02115, USA
    J Neurooncol 72:77-84. 2005
    ..More importantly, we report on the first two survivors after relapse with multi-agent intravenous and intrathecal chemotherapy treated with this modified regimen...
  5. doi request reprint Predictors of neoplastic disease in children with isolated pituitary stalk thickening
    Nathan J Robison
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston Children s Hospital, Boston, MA, USA
    Pediatr Blood Cancer 60:1630-5. 2013
    ..The significance of pituitary stalk thickening (PST) on magnetic resonance imaging (MRI) is often unclear. We evaluated presenting symptoms, MRI findings, clinical course, and outcome predictors of patients with PST...
  6. ncbi request reprint A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer
    Mark W Kieran
    Department of Pediatric Oncology, Dana Farber Cancer Institute, and Division of Pediatric Hematology Oncology, Children s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Pediatr Hematol Oncol 27:573-81. 2005
    ....
  7. ncbi request reprint Transverse myelitis after therapy for primitive neuroectodermal tumors
    Nicole J Ullrich
    Department of Neurology, Children s Hospital Boston and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Pediatr Neurol 35:122-5. 2006
    ....
  8. ncbi request reprint Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database
    Pratiti Bandopadhayay
    Division of Pediatric Hematology Oncology, Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston Children s Hospital, Boston, Massachusetts Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts
    Pediatr Blood Cancer 61:1173-9. 2014
    ..We identified patients diagnosed with PLGG diagnosed between 1973 and 2008 through the Surveillance Epidemiology and End Results (SEER) database to examine outcomes of adult survivors of PLGG...
  9. pmc Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors
    Mark W Kieran
    Director, Pediatric Medical Neuro Oncology, Dana Farber Cancer Institute and Boston Children s Hospital, Pediatric Hematology Oncology, Boston, MA 02215, USA
    Pediatr Blood Cancer 59:1155-7. 2012
    ..Targeted therapy in this disease would benefit from advanced technologies detecting relevant actionable mutations...
  10. doi request reprint Sleep dysfunction in long term survivors of craniopharyngioma
    Peter E Manley
    Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Neurooncol 108:543-9. 2012
    ..Patients with a higher BMI were more likely to experience sleep disturbance. Formal sleep evaluations should be considered in all patients with craniopharyngioma...
  11. doi request reprint Germinoma with malignant transformation to nongerminomatous germ cell tumor
    Judith M Wong
    Department of Neurosurgery, Brigham and Women s Hospital, Boston, MA, USA
    J Neurosurg Pediatr 6:295-8. 2010
    ..To the authors' knowledge, this is the first case in the English-language literature of a nongerminomatous germ cell tumor resulting from conversion of germinoma at the original site of presentation...
  12. pmc Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas
    Matija Snuderl
    Pathology Service, Massachusetts General Hospital, Boston, MA 02114, USA
    J Neuropathol Exp Neurol 67:911-20. 2008
    ....
  13. ncbi request reprint The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience
    Susan N Chi
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Pediatr Blood Cancer 42:46-51. 2004
    ..To further investigate this hypothesis, the relapse patterns among groups receiving chemotherapy regimens of variable intensity at Memorial Sloan-Kettering Cancer Center were analyzed...
  14. ncbi request reprint Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue
    Stergios Zacharoulis
    Department of Pediatric Hematology Oncology, Children s Hospital Los Angdes, Neural Tumors Program, Los Angles, CA 900 27, USA
    Pediatr Blood Cancer 49:34-40. 2007
    ....